Altieri D C
Boyer Center for Molecular Medicine, Department of Pathology, Yale University School of Medicine, New Haven, CT 06536, USA.
Semin Cell Biol. 1995 Oct;6(5):269-74. doi: 10.1006/scel.1995.0036.
Vascular cells, and leukocytes in particular, have evolved a formidable machinery to initiate and amplify coagulation. Through multiple, receptor-mediated recognitions this process provides a cellular microenvironment of limited proteolytic activation that contributes to the maintenance of the hemostatic balance in vivo. However, the ability of leukocytes to generate thrombin is also a fundamental aspect of inflammatory responses, and has far-reaching implications in the pathophysiology of vascular diseases. The scope of this article is to revisit the most recent contributions to the cellular and molecular mechanisms of leukocyte-mediated coagulation, and to highlight their role in the pathogenesis of vascular injury.
血管细胞,尤其是白细胞,已经进化出一套强大的机制来启动和放大凝血过程。通过多种受体介导的识别,这一过程提供了一个有限蛋白水解激活的细胞微环境,有助于维持体内的止血平衡。然而,白细胞产生凝血酶的能力也是炎症反应的一个基本方面,并且在血管疾病的病理生理学中具有深远的影响。本文的范围是重新审视白细胞介导凝血的细胞和分子机制的最新研究成果,并强调它们在血管损伤发病机制中的作用。